We looked at the GIN values separately in the three breast cancer (BC) subtypes (hormone receptor-expressing (HR+) (n = 9), HER2 amplified or overexpressed (HER2+) (n = 7) and triple-negative breast cancer (TNBC) (n = 9). This evidence concerns the gene NR4A1 and breast carcinoma.